Target Price | $103.00 |
Price | $2.59 |
Potential |
3,876.83%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Citius Pharmaceuticals Inc 2026 .
The average Citius Pharmaceuticals Inc target price is $103.00.
This is
3,876.83%
register free of charge
$200.00
7,622.01%
register free of charge
$9.00
247.49%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Citius Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Citius Pharmaceuticals Inc stock has an average upside potential 2026 of
3,876.83%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.97 | -0.51 |
7.18% | 91.46% | |
P/E | negative | |
EV/Sales | 0.59 |
2 Analysts have issued a Citius Pharmaceuticals Inc forecast for earnings per share. The average Citius Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Citius Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.